{"id":567,"date":"2025-07-09T16:16:25","date_gmt":"2025-07-09T13:16:25","guid":{"rendered":"https:\/\/mbpharma.ru\/?p=567"},"modified":"2025-07-09T18:04:36","modified_gmt":"2025-07-09T15:04:36","slug":"interview-s-generalnym-direktorom-mbf","status":"publish","type":"post","link":"https:\/\/mbpharma.ru\/en\/interview-s-generalnym-direktorom-mbf\/","title":{"rendered":"An Interview with MiraxBioPharma\u2019s CEO"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-568 size-full\" src=\"https:\/\/mbpharma.ru\/wp-content\/uploads\/2025\/07\/prevyu-intervyu_page-0001.jpg\" alt=\"\" width=\"2000\" height=\"1125\" srcset=\"https:\/\/mbpharma.ru\/wp-content\/uploads\/2025\/07\/prevyu-intervyu_page-0001.jpg 2000w, https:\/\/mbpharma.ru\/wp-content\/uploads\/2025\/07\/prevyu-intervyu_page-0001-300x169.jpg 300w, https:\/\/mbpharma.ru\/wp-content\/uploads\/2025\/07\/prevyu-intervyu_page-0001-1024x576.jpg 1024w, https:\/\/mbpharma.ru\/wp-content\/uploads\/2025\/07\/prevyu-intervyu_page-0001-768x432.jpg 768w, https:\/\/mbpharma.ru\/wp-content\/uploads\/2025\/07\/prevyu-intervyu_page-0001-1536x864.jpg 1536w, https:\/\/mbpharma.ru\/wp-content\/uploads\/2025\/07\/prevyu-intervyu_page-0001-18x10.jpg 18w\" sizes=\"auto, (max-width: 2000px) 100vw, 2000px\" \/><\/p>\n<p>A major interview with Vadim Drukh, General Director of MiraxBioPharma JSC, was published on one of the leading industry platforms \u2013 pharmvestnik.ru. The dialogue touched upon the Company\u2019s rebranding, strategic directions, and pharmaceutical market evolution. The conversation was both engaging and candid \u2014 we invite you <a href=\"https:\/\/pharmvestnik.ru\/content\/interviews\/Vadim-Druh-Esli-razrabotka-silnaya-ona-budet-vostrebovana-na-lubyh-rynkah-i-v-luboe-vremya.html\" target=\"_blank\" rel=\"noopener\">to read it<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Brand transformation \u2014 first-hand account<\/p>","protected":false},"author":7,"featured_media":568,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-567","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/posts\/567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/comments?post=567"}],"version-history":[{"count":8,"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/posts\/567\/revisions"}],"predecessor-version":[{"id":580,"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/posts\/567\/revisions\/580"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/media\/568"}],"wp:attachment":[{"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/media?parent=567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/categories?post=567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mbpharma.ru\/en\/wp-json\/wp\/v2\/tags?post=567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}